|
시장보고서
상품코드
2064746
당화 알부민 검사 시장 규모, 점유율 및 성장 분석 : 측정법별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)Glycated Albumin Assay Market Size, Share, and Growth Analysis, By Method (Enzymatic Assay, Colorimetric Assay), By Application (Diabetes Management, Chronic Kidney Disease Monitoring), By End-User, By Region - Industry Forecast 2026-2033 |
||||||
세계의 당화 알부민 검사 시장 규모는 2024년에 4억 7,079만 달러로 평가되었고, 2025년 5억 916만 달러에서 2033년까지 9억 5,294만 달러로 확대되어 예측 기간(2026-2033년)에 CAGR 8.15%를 기록할 것으로 예측됩니다.
세계 당화 알부민 검사 시장은 주로 당뇨병 유병률 증가와 기존의 A1c 검사를 보완할 중간 단계의 혈당 수치 평가 필요성에 힘입어 성장하고 있습니다. 당화 알부민은 특히 헤모글로빈 검사만으로는 정확한 평가가 어려운 경우, 수 주간에 걸친 평균 혈당 수치에 대한 정보를 제공합니다. 이 시장은 기술 및 제품 개발의 진보를 반영하여, 복잡한 면역 측정 키트에서 보다 효율적인 자동화 시스템으로 발전해 왔습니다. 또한, 검사실과 진료소에서 인슐린 조절 및 임신성 당뇨병 모니터링을 위해 이러한 검사를 점점 더 많이 도입함에 따라, 규제 당국의 승인 및 보험 급여 정책이 임상 실무를 형성하는 데 중요한 역할을 하고 있습니다. 이러한 이용 증가는 비용 대비 효과를 높여, 제조업체들이 현장 진단(POC)용 제품 개발을 추진하는 계기가 되었으며, 이러한 필수적인 진단 도구에 대한 접근성을 더욱 확대되고 있습니다.
세계 당화 알부민 검사 시장의 성장 요인
세계 당화 알부민 검사 시장의 주요 성장 요인 중 하나는 전 세계적으로 당뇨병 및 관련 합병증의 유병률이 증가하고 있다는 점입니다. 의료진과 환자들이 장기적인 혈당 조절을 모니터링할 수 있는 보다 정확한 방법을 모색함에 따라, 당화알부민 검사에 대한 수요가 급증하고 있습니다. 이러한 검사는 특히 헤모글로빈 변이체가 결과에 영향을 미칠 가능성이 있는 상황에서 기존의 헤모글로빈 A1c 검사를 대체할 수 있는 신뢰할 수 있는 대안을 제공합니다. 또한, 당뇨병을 효과적으로 관리하는 것의 중요성에 대한 인식이 높아지고 진단 기술이 발전함에 따라 당화 알부민 검사의 도입이 촉진되고 있으며, 이로 인해 시장 성장이 크게 견인되고 있습니다.
세계 당화 알부민 검사 시장의 제약 요인
세계 당화 알부민 검사 시장의 주요 시장 제약 요인은 표준화된 검사 프로토콜의 부재와 지역별 검사실 실무 관행의 차이입니다. 이러한 불일치는 검사 결과의 불일치를 초래하여, 의료 종사자들 사이에서 당화 알부민 검사의 신뢰성과 보급을 제한할 가능성이 있습니다. 또한, HbA1c와 같은 확립된 바이오마커와의 경쟁, 임상의들이 기존 방법을 선호하는 경향이 당화 알부민 검사의 일상적인 임상 진료 도입을 저해할 가능성이 있습니다. 또한, 각 지역의 의료 예산 제약으로 인해 첨단 진단 검사의 이용이 제한되어 시장 성장을 더욱 저해할 가능성이 있습니다.
세계 당화 알부민 검사 시장 동향
세계 당화 알부민 검사 시장에서는 분산형 검사로의 전환을 특징으로 하는 현장 진단(POC)의 확대를 향한 뚜렷한 추세가 나타나고 있습니다. 이러한 추세는 외래 진료소, 지역 검사 기관, 전문 의료 센터에서 당화 알부민 검사에 대한 수요가 증가함에 따라 주도되고 있으며, 이러한 현장에서는 시기적절하고 정확한 검사 결과가 환자 관리에 큰 영향을 미치기 때문입니다. 이러한 검사의 장점은 편의성, 신속한 결과 보고, 그리고 소형 기기와의 호환성에 있으며, 이를 통해 의료진과 환자 모두에게 접근성이 향상됩니다. 진단 서비스 기업과 현장 진단(Point-of-Care) 기술 제조업체 간의 협력을 통해 당화 알부민 검사가 표준 임상 진료에 더욱 널리 도입되고 있으며, 이에 따라 당뇨병 관리 및 환자 치료에서 이 검사의 역할이 확고해지고 있습니다.
목차
서론
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 당화 알부민 검사 시장 규모 : 방법별
세계의 당화 알부민 검사 시장 규모 : 용도별
세계의 당화 알부민 검사 시장 규모 : 최종사용자별
세계의 당화 알부민 검사 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
LSHGlobal Glycated Albumin Assay Market size was valued at USD 470.79 Million in 2024 and is poised to grow from USD 509.16 Million in 2025 to USD 952.94 Million by 2033, growing at a CAGR of 8.15% during the forecast period (2026-2033).
The global glycated albumin assay market is primarily driven by the rising prevalence of diabetes and the need for intermediate glycemic assessments to supplement traditional A1c tests. Glycated albumin offers insights into average blood sugar levels over a few weeks, especially when hemoglobin tests are not viable for accurate evaluations. The market has evolved from complex immunoassay kits to more efficient automated systems, reflecting advancements in technology and product development. Additionally, regulatory approvals and reimbursement policies play crucial roles in shaping clinical practices, as laboratories and clinics increasingly adopt these assays for monitoring insulin adjustments and gestational diabetes. This increased usage enhances cost efficiency, prompting manufacturers to develop point-of-care versions, further broadening access to these essential diagnostic tools.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Glycated Albumin Assay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Glycated Albumin Assay Market Segments Analysis
Global glycated albumin assay market is segmented by method, application, end-user and region. Based on method, the market is segmented into Enzymatic Assay, Colorimetric Assay and Others. Based on application, the market is segmented into Diabetes Management, Chronic Kidney Disease Monitoring and Others. Based on end-user, the market is segmented into Hospitals, Diagnostic Centers and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Glycated Albumin Assay Market
One of the key market drivers for the Global Glycated Albumin Assay Market is the increasing prevalence of diabetes and related complications worldwide. As healthcare providers and patients seek more accurate methods to monitor long-term glycemic control, the demand for glycated albumin assays has surged. These assays offer a reliable alternative to traditional hemoglobin A1c tests, especially in circumstances where hemoglobin variants may interfere with results. Furthermore, the rising awareness of the importance of managing diabetes effectively and advancements in diagnostic technologies are propelling the adoption of glycated albumin testing, thereby driving market growth significantly.
Restraints in the Global Glycated Albumin Assay Market
A significant market restraint for the global glycated albumin assay market is the lack of standardized testing protocols and variations in laboratory practices across different regions. This inconsistency can lead to discrepancies in test results, limiting the reliability and widespread adoption of glycated albumin assays among healthcare providers. Furthermore, the competition from established biomarkers like HbA1c and the preference of clinicians for more conventional methods may hinder the integration of glycated albumin tests into routine clinical practice. Additionally, healthcare budget constraints in various regions may restrict the availability of advanced diagnostic assays, further impeding market growth.
Market Trends of the Global Glycated Albumin Assay Market
The Global Glycated Albumin Assay market is experiencing a significant trend towards point-of-care expansion, characterized by a shift towards decentralized testing. This movement is driven by the increasing demand for glycated albumin tests in outpatient clinics, community laboratories, and specialty care centers, where timely and relevant results can significantly influence patient management. The appeal of these tests lies in their convenience, rapid turnaround times, and compatibility with compact devices, which enhance accessibility for both healthcare providers and patients. Collaborative efforts between diagnostic service firms and manufacturers of point-of-care technologies are further fostering the integration of glycated albumin assays into standard clinical practices, thereby solidifying their role in diabetes management and patient care.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Glycated Albumin Assay Market Size by Method & CAGR (2026-2033)
- Market Overview
- Enzymatic Assay
- Colorimetric Assay
- Others
Global Glycated Albumin Assay Market Size by Application & CAGR (2026-2033)
- Market Overview
- Diabetes Management
- Chronic Kidney Disease Monitoring
- Others
Global Glycated Albumin Assay Market Size by End-User & CAGR (2026-2033)
- Market Overview
- Hospitals
- Diagnostic Centers
- Research Institutes
Global Glycated Albumin Assay Market Size & CAGR (2026-2033)
- North America (Method, Application, End-User)
- US
- Canada
- Europe (Method, Application, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Method, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Method, Application, End-User)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Method, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Asahi Kasei
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Roche Holding
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Energy
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sysmex Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LifeSpan BioSciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MyBioSource
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cusabio Technology
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Wuhan Fine Biotech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Randox Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Diazyme Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abnova Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Kamiya Biomedical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Genzyme
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- DiaSys Diagnostic Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biotech Atlantic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
